North America Syringes and Needles Market Outlook to 2021

  • ID: 3759326
  • Report
  • Region: America, North America, United States
  • 126 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Covidien plc
  • Nipro Corporation
  • Smiths Medical
  • MORE
North America Syringes and Needles Market Outlook to 2021

Summary

Our new report, "North America Syringes and Needles Market Outlook to 2021", provides key market data on the North America Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syringes.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Syringes and Needles market segments - General Syringes and Specialized Syringes.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Syringes and Needles market.
- Global corporate-level profiles of key companies operating within the North America Syringes and Needles market.
- Key players covered include Becton, Dickinson and Company, Covidien plc, B. Braun Melsungen AG, Nipro Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Covidien plc
  • Nipro Corporation
  • Smiths Medical
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Syringes and Needles Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Syringes and Needles Market, North America

3.1 Syringes and Needles Market, North America, Revenue ($m), 2007-2021

3.2 Syringes and Needles Market, North America, Revenue ($m), 2007-2014

3.3 Syringes and Needles Market, North America, Revenue ($m), 2014-2021

3.4 Syringes and Needles Market, North America, Volume (Units), 2007-2021

3.5 Syringes and Needles Market, North America, Volume (Units), 2007-2014

3.6 Syringes and Needles Market, North America, Volume (Units), 2014-2021

3.7 Syringes and Needles Market, North America, Company Share by Revenue ($m), 2014

4 Syringes and Needles Market, Canada

4.1 Syringes and Needles Market, Canada, Revenue ($m), 2007-2014

4.2 Syringes and Needles Market, Canada, Revenue ($m), 2014-2021

4.3 Syringes and Needles Market, Canada, Volume (Units), 2007-2014

4.4 Syringes and Needles Market, Canada, Volume (Units), 2014-2021

4.5 Syringes and Needles Market, Canada, Average Price ($), 2007-2021

4.6 Syringes and Needles Market, Canada, Distribution Share by Revenue ($m), 2013-2014

4.7 Syringes and Needles Market, Canada, Company Share by Revenue ($m), 2014

5 Syringes and Needles Market, Mexico

5.1 Syringes and Needles Market, Mexico, Revenue ($m), 2007-2014

5.2 Syringes and Needles Market, Mexico, Revenue ($m), 2014-2021

5.3 Syringes and Needles Market, Mexico, Volume (Units), 2007-2014

5.4 Syringes and Needles Market, Mexico, Volume (Units), 2014-2021

5.5 Syringes and Needles Market, Mexico, Average Price ($), 2007-2021

5.6 Syringes and Needles Market, Mexico, Distribution Share by Revenue ($m), 2013-2014

5.7 Syringes and Needles Market, Mexico, Company Share by Revenue ($m), 2014

6 Syringes and Needles Market, United States

6.1 Syringes and Needles Market, United States, Revenue ($m), 2007-2014

6.2 Syringes and Needles Market, United States, Revenue ($m), 2014-2021

6.3 Syringes and Needles Market, United States, Volume (Units), 2007-2014

6.4 Syringes and Needles Market, United States, Volume (Units), 2014-2021

6.5 Syringes and Needles Market, United States, Average Price ($), 2007-2021

6.6 Syringes and Needles Market, United States, Distribution Share by Revenue ($m), 2013-2014

6.7 Syringes and Needles Market, United States, Company Share by Revenue ($m), 2014

7 Overview of Key Companies in North America Syringes and Needles Market

7.1 Becton, Dickinson and Company

7.1.1 Company Overview

7.2 B. Braun Melsungen AG

7.2.1 Company Overview

7.3 Nipro Corporation

7.3.1 Company Overview

7.4 Baxter International Inc.

7.4.1 Company Overview

7.5 Smiths Medical

7.5.1 Company Overview

7.6 Covidien plc

7.6.1 Company Overview

8 Syringes and Needles Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications

9.1.1 Feb 25, 2016: Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations

9.1.2 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences

9.1.3 Aug 25, 2015: Unilife Appoints Harry Hamill to the Board of Directors

9.1.4 Aug 03, 2015: Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer

9.1.5 Aug 01, 2015: SPARC Receives Complete Response Letter from USFDA for Latanoprost NDA

9.1.6 Jun 03, 2015: Bristol-Myers Squibb to Present Data from 14 Abstracts on Orencia (abatacept) at the European League Against Rheumatism (EULAR) 2015 Annual Meeting

9.1.7 Apr 16, 2015: Sagent Pharmaceuticals Appoints Michael Logerfo as President

9.1.8 Apr 16, 2015: Shlomo Yanai Joins Sagent Pharmaceuticals Board of Directors

9.1.9 Apr 08, 2015: Unilife Appoints Dr. Richard Beckman as Chief Medical Officer

9.1.10 Mar 26, 2015: Sagent Pharmaceuticals Announces Leadership Changes

9.2 Financial Announcements

9.2.1 Feb 16, 2016: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results

9.2.2 Feb 09, 2016: Unilife Announces Financial Results For the Second Quarter of Fiscal Year 2016

9.2.3 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter

9.2.4 Nov 09, 2015: Unilife Announces Financial Results For the First Quarter of Fiscal Year 2016

9.2.5 Nov 04, 2015: BD Announces Results For 2015 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2016 Guidance

9.2.6 Oct 13, 2015: Spring Bank Pharmaceuticals Announces Presentation of Results from Phase I Clinical Trial Supporting the Novel Mechanism of Action of SB 9200 in Patients with Hepatitis C at The Liver Meeting

9.2.7 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015

9.2.8 Sep 14, 2015: Unilife Corporation Announces Financial Results For the Fourth Quarter and Full Fiscal Year 2015

9.2.9 Aug 14, 2015: Retractable Technologies Reports Results as of June 30, 2015

9.2.10 Aug 06, 2015: BD Announces Results for 2015 Third Fiscal Quarter and Raises EPS Guidance for Fiscal 2015

9.2.11 Aug 04, 2015: Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results

9.2.12 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results

9.2.13 Jul 28, 2015: Centinel Spine Implants Its First STALIF MIDLINE II-Ti Device

9.2.14 May 15, 2015: Retractable Technologies Reports Improved Results for the First Quarter 2015

9.2.15 May 11, 2015: Unilife Announces Financial Results For Fiscal Year 2015 Third Quarter

9.2.16 May 07, 2015: BD Announces Results For 2015 Second Fiscal Quarter

9.2.17 May 05, 2015: Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results

9.2.18 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results

9.2.19 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System

9.2.20 Apr 16, 2015: Arch Therapeutics' AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study

9.2.21 Apr 07, 2015: Dualis MedTech and ReliantHeart Partner on Fully Implantable TET System for the HeartAssist5 LVAD

9.2.22 Apr 01, 2015: Retractable Technologies Reports Results for the Three and Twelve Months Ended December 31, 2014

9.3 Legal And Regulatory

9.3.1 Jul 23, 2015: Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials

9.3.2 May 21, 2015: Retractable Technologies Reports Recognition of Payment

9.3.3 May 01, 2015: Hospira Statement On FDA's Final Biosimilar Guidance Documents

9.3.4 Apr 27, 2015: Retractable Technologies Announces Amended Final Judgment and Notice of Appeal

9.3.5 Apr 21, 2015: Retractable Technologies Announces U.S. Supreme Court Decision - Denial of Writ of Certiorari

9.3.6 Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant

9.3.7 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines

9.4 Other Significant Developments

9.4.1 Mar 14, 2016: Unilife Realigns Business Units and Leadership Team

9.4.2 Dec 07, 2015: ARxIUM Selects Additional Distributors of RIVA Automated Compounding System for Asia-Pacific Region

9.4.3 Nov 03, 2015: Sigma-Aldrich Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00

9.4.4 Oct 20, 2015: ARxIUM Selects Silver Wing Asia-Pacific International Medical Technology Company as its Exclusive Distributor of RIVA Automated Compounding System in Mainland China

9.4.5 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes

9.4.6 Sep 15, 2015: BD Named 2015 Outstanding Corporate Innovator Winner by Product Development and Management Association

9.4.7 May 07, 2015: Sigma-Aldrich Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend.

9.4.8 May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement

9.4.9 Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche

9.4.10 Mar 19, 2015: Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich

9.5 Product News

9.5.1 Oct 05, 2015: Galil Medical Launches New Family Of Cryoablation Needles

9.5.2 Apr 13, 2015: Cadence Announces New LaserSwiss Capability

9.6 Strategy And Business Planning

9.6.1 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges

9.6.2 Jan 20, 2016: West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems

9.6.3 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma

9.6.4 Jul 13, 2015: BD Announces Sustainability Goals for 2020

9.6.5 Jul 08, 2015: BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts

9.6.6 May 21, 2015: Cadence Announces Major Expansion of Wisconsin Facility

9.6.7 May 18, 2015: Haselmeier Group Announces the Relocation of Haselmeier in the United States

9.6.8 May 12, 2015: SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling

9.6.9 Apr 17, 2015: Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia

9.6.10 Apr 06, 2015: Breakout Labs and Becton, Dickinson and Company Partner to Provide Capital and Expertise to Biomedical Startups

10 Appendix

10.1 Research Methodology

10.1.1 Coverage

10.1.2 Secondary Research

10.1.3 Primary Research

10.1.4 Company Share Analysis

10.1.5 Distribution Share Analysis

10.2 Consulting

10.3 Contact Us

10.4 Disclaimer

1.1 List of Tables

Table 1: Syringes and Needles Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021

Table 2: Syringes and Needles Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014

Table 3: Syringes and Needles Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021

Table 4: Syringes and Needles Market, North America, Volume (Units), 2007-2021

Table 5: Syringes and Needles Market, North America, Volume (Units), Historic, 2007-2014

Table 6: Syringes and Needles Market, North America, Volume (Units), Forecast, 2014-2021

Table 7: Syringes and Needles Market, North America, Company Share by Revenue ($m), USD Constant, 2014

Table 8: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014

Table 9: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021

Table 10: Syringes and Needles Market, Canada, Volume (Units), Historic, 2007-2014

Table 11: Syringes and Needles Market, Canada, Volume (Units), Forecast, 2014-2021

Table 12: Syringes and Needles Market, Canada, Average Price ($), Historic, 2007-2014

Table 13: Syringes and Needles Market, Canada, Average Price ($), Forecast, 2014-2021

Table 14: Syringes and Needles Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014

Table 15: Syringes and Needles Market, Canada, Company Share by Revenue ($m), USD Constant, 2014

Table 16: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014

Table 17: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021

Table 18: Syringes and Needles Market, Mexico, Volume (Units), Historic, 2007-2014

Table 19: Syringes and Needles Market, Mexico, Volume (Units), Forecast, 2014-2021

Table 20: Syringes and Needles Market, Mexico, Average Price ($), Historic, 2007-2014

Table 21: Syringes and Needles Market, Mexico, Average Price ($), Forecast, 2014-2021

Table 22: Syringes and Needles Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014

Table 23: Syringes and Needles Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014

Table 24: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014

Table 25: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021

Table 26: Syringes and Needles Market, United States, Volume (Units), Historic, 2007-2014

Table 27: Syringes and Needles Market, United States, Volume (Units), Forecast, 2014-2021

Table 28: Syringes and Needles Market, United States, Average Price ($), Historic, 2007-2014

Table 29: Syringes and Needles Market, United States, Average Price ($), Forecast, 2014-2021

Table 30: Syringes and Needles Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014

Table 31: Syringes and Needles Market, United States, Company Share by Revenue ($m), USD Constant, 2014

Table 32: Syringes and Needles Market Pipeline Products

1.2 List of Figures

Figure 1: Syringes and Needles Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021

Figure 2: Syringes and Needles Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014

Figure 3: Syringes and Needles Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021

Figure 4: Syringes and Needles Market, North America, Volume (Units), 2007-2021

Figure 5: Syringes and Needles Market, North America, Volume (Units), Historic, 2007-2014

Figure 6: Syringes and Needles Market, North America, Volume (Units), Forecast, 2014-2021

Figure 7: Syringes and Needles Market, North America, Company Share (%) 2014

Figure 8: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014

Figure 9: Syringes and Needles Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021

Figure 10: Syringes and Needles Market, Canada, Volume (Units), Historic, 2007-2014

Figure 11: Syringes and Needles Market, Canada, Volume (Units), Forecast, 2014-2021

Figure 12: Syringes and Needles Market, Canada, Company Share (%) 2014

Figure 13: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014

Figure 14: Syringes and Needles Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021

Figure 15: Syringes and Needles Market, Mexico, Volume (Units), Historic, 2007-2014

Figure 16: Syringes and Needles Market, Mexico, Volume (Units), Forecast, 2014-2021

Figure 17: Syringes and Needles Market, Mexico, Company Share (%) 2014

Figure 18: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014

Figure 19: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021

Figure 20: Syringes and Needles Market, United States, Volume (Units), Historic, 2007-2014

Figure 21: Syringes and Needles Market, United States, Volume (Units), Forecast, 2014-2021

Figure 22: Syringes and Needles Market, United States, Company Share (%) 2014
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Becton, Dickinson and Company
B. Braun Melsungen AG
Nipro Corporation
Baxter International Inc.
Smiths Medical
Covidien plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll